Search Results - "Kruger, Gertruida"
-
1
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Published in The New England journal of medicine (20-05-2021)“…A randomized, phase 2 trial compared the NVX-CoV2373 nanoparticle vaccine with placebo in participants in South Africa, including 30% who were seropositive at…”
Get full text
Journal Article -
2
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Published in Scientific reports (21-01-2023)“…The SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern (VOC) and its sub-lineages (including BA.2, BA.4, BA.5, BA.2.12.1) contain spike mutations that confer…”
Get full text
Journal Article -
3
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
Published in The lancet HIV (01-05-2022)“…There is a paucity of data on COVID-19 vaccines in people living with HIV-1, who could be at increased risk of severe illness and death from COVID-19. We…”
Get full text
Journal Article